Virtual Eye Movement Desensitisation and Reprocessing (EMDR) trial in Australian Veterans with Posttraumatic Stress Disorder (PTSD)

Not Applicable

• Conditions: Posttraumatic Stress Disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12622000249752
• Lead Sponsor: Concord Repatriation General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-11
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Australian veterans attending the National Centre for Veterans' Healthcare (NCVH)
2. Department of Veterans’ Affairs (DVA) accepted clinical diagnosis of PTSD, which have been confirmed by NCVH clinicians administering and trained in the Structured Clinical Interview for DSM 5 (SCID-5)
3. Suitable for treatment with EMDR

Exclusion Criteria

1.No prior treatment with EMDR
2.No history of acquired brain injury from any cause, which may increase the risk of developing PTSD but the impact of acquired brain injury on treatment for PTSD with EMDR is currently unknown
3.No active alcohol, benzodiazepine, or illicit substance use, which are common comorbidities among patients with PTSD but are generally considered relative contraindications for EMDR on the basis of their effects on long term potentiation

Study & Design

• Study Type: Interventional
• Study Design: Not specified